{"schema_version":"1","generated_at":"2026-10-31T03:31:20.149Z","data_as_of":"2026-10-28","url":"https://www.findmykol.com/kol/julie-krystal","json_url":"https://www.findmykol.com/kol/julie-krystal/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"julie-krystal","name":"Julie Krystal","credential":"MD","title":"Assistant Professor, Head of Developmental Therapeutics","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Leukemia","therapeutic_areas":["Leukemia","Neuro-Oncology"],"institution":"Cohen Children's Medical Center","institution_url":"https://www.findmykol.com/institution/cohen-children-s-medical-center","city":"New Hyde Park","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1689952269","orcid":"0000-0002-7997-1015","openalex":"A5000934222"},"summary":"Julie Krystal is Assistant Professor, Head of Developmental Therapeutics at Cohen Children's Medical Center. OpenAlex indexes 35 publications with 264 citations (h-index 7); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Julie Krystal, MD, is Assistant Professor, Head of Developmental Therapeutics at Cohen Children's Medical Center. The public record shows 35 publications with 264 citations (h-index 7), centered on Acute Lymphoblastic Leukemia research, Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 1 companies.","bullets":["Most recent indexed publication: 2025 · Pediatric blood & cancer","Top research focus: Acute Lymphoblastic Leukemia research","3 registered trials on ClinicalTrials.gov","Open Payments reporting from 1 companies"],"generated_at":"2026-10-30"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":2,"topics":1,"strength":7},{"label":"Glioma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":1,"topics":2,"strength":5},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Gliosarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Coma","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Diffuse Intrinsic Pontine Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Optic Nerve Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Acute Lymphoblastic Leukemia research","Glioma Diagnosis and Treatment","Cancer Immunotherapy and Biomarkers","Neurofibromatosis and Schwannoma Cases","Chronic Myeloid Leukemia Treatments"],"drugs_studied":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Ojemda","generic":"Tovorafenib","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Day One Biopharmaceuticals","trials":0,"payments":2,"mentions":2},{"name":"National Cancer Institute (NCI)","trials":2,"payments":0,"mentions":2},{"name":"Julie Krystal","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":35,"cited_by_count":264,"h_index":7,"i10_index":7,"pubmed_count":9,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06317662","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT06317662","trial_url":"https://www.findmykol.com/trial/NCT06317662"},{"nct":"NCT05099003","title":"A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT05099003","trial_url":"https://www.findmykol.com/trial/NCT05099003"},{"nct":"NCT01837862","title":"A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"Julie Krystal","source_url":"https://clinicaltrials.gov/study/NCT01837862","trial_url":"https://www.findmykol.com/trial/NCT01837862"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2025,"last":2025},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Day One Biopharmaceuticals","program_year":2025,"amount_usd":4537.5,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689952269"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1689952269","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":6,"years":{"first":2021,"last":2024},"societies":["ASCO","ASH","ESMO"],"shown":3,"withheld":3,"rows":[{"title":"Safety, efficacy, and PKPD of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced or metastatic ovarian cancer: Results from a multi-center multi-country phase 1/2a expansion cohort.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.5575","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.5575","status":"verified"},{"title":"Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study","society":"ASH","meeting":"ASH Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2024-199263","source_url":"https://doi.org/10.1182/blood-2024-199263","status":"verified"},{"title":"1706P Efficacy, safety and PKPD of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced or metastatic clear-cell renal cell carcinoma (ccRCC): Results from a multi-center multi-country phase I/IIa expansion cohort","society":"ESMO","meeting":"ESMO Congress","year":2024,"role":"presenting_author","presentation_type":"poster","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.annonc.2024.08.1799","source_url":"https://doi.org/10.1016/j.annonc.2024.08.1799","status":"verified"}],"source":"congress"},"publications":{"total":9,"shown":5,"withheld":4,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.","year":2025,"journal":"Pediatric blood & cancer","types":["Journal Article","Clinical Trial, Phase I","Clinical Trial, Phase II","Multicenter Study","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40313040/","status":"verified"},{"title":"A phase 1 study of mebendazole with bevacizumab and irinotecan in high-grade gliomas.","year":2024,"journal":"Pediatric blood & cancer","types":["Clinical Trial, Phase I","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38234020/","status":"verified"},{"title":"Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.","year":2024,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Clinical Trial, Phase I","Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38033284/","status":"verified"},{"title":"Treatment of High-Risk Neuroblastoma.","year":2023,"journal":"Children (Basel, Switzerland)","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37628301/","status":"verified"},{"title":"New pediatric leukemia/lymphoma diagnoses during the COVID-19 pandemic: A New York perspective.","year":2023,"journal":"Pediatric blood & cancer","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/35870156/","status":"verified"}],"most_cited":{"total":35,"shown":5,"withheld":30,"rows":[{"title":"Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma","year":2022,"cited_by_count":63,"type":"article","source_url":"https://doi.org/10.1093/neuonc/noac096"},{"title":"Treatment of High-Risk Neuroblastoma","year":2023,"cited_by_count":43,"type":"review","source_url":"https://doi.org/10.3390/children10081302"},{"title":"Arterial stiffness in childhood cancer survivors","year":2015,"cited_by_count":42,"type":"article","source_url":"https://doi.org/10.1002/pbc.25547"},{"title":"Stem Cell Transplant for Children with Sickle Cell Anemia: Parent and Patient Interest","year":2012,"cited_by_count":39,"type":"article","source_url":"https://doi.org/10.1016/j.bbmt.2012.05.013"},{"title":"Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921","year":2023,"cited_by_count":17,"type":"article","source_url":"https://doi.org/10.1200/jco.23.00897"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Mark P. Atlas","coauthored_works":6},{"name":"Jonathan D. Fish","coauthored_works":5},{"name":"Nobuko Hijiya","coauthored_works":5}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/julie-krystal-md","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, New York Medical College (graduated 2009), per directory aggregator","source_url":"https://connect.medicalnewstoday.com/provider/dr-julie-krystal-1689952269","status":"provisional","collected_at":"2026-10-30"},{"value":"Board certified in Pediatric Hematology-Oncology and Pediatrics, per directory aggregator","source_url":"https://connect.medicalnewstoday.com/provider/dr-julie-krystal-1689952269","status":"provisional","collected_at":"2026-10-30"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Hospital affiliations listed by directory aggregator: Long Island Jewish Medical Center, North Shore University Hospital, South Shore University Hospital, St Charles Hospital","source_url":"https://connect.medicalnewstoday.com/provider/dr-julie-krystal-1689952269","status":"provisional","collected_at":"2026-10-30"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Guest, Medical School HQ episode 38 (MedEd Media), pediatric oncology career discussion","source_url":"https://medicalschoolhq.net/ss-38-discussing-pediatric-oncology-with-an-academic-doc/","status":"verified","collected_at":"2026-10-30"}]}},"similar":[{"name":"James Markowitz","slug":"james-markowitz","institution":"Cohen Children's Medical Center","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/james-markowitz","json_url":"https://www.findmykol.com/kol/james-markowitz/profile.json"},{"name":"Sanjeev Kothare","slug":"sanjeev-kothare","institution":"Cohen Children's Medical Center","specialty":"Neurology with Special Qualifications in Child Neurology","url":"https://www.findmykol.com/kol/sanjeev-kothare","json_url":"https://www.findmykol.com/kol/sanjeev-kothare/profile.json"},{"name":"Ira Parness","slug":"ira-parness","institution":"Cohen Children's Medical Center","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/ira-parness","json_url":"https://www.findmykol.com/kol/ira-parness/profile.json"},{"name":"Martin Bialer","slug":"martin-bialer","institution":"Cohen Children's Medical Center","specialty":"Clinical Genetics (M.D.)","url":"https://www.findmykol.com/kol/martin-bialer","json_url":"https://www.findmykol.com/kol/martin-bialer/profile.json"},{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Jorge Cortes","slug":"jorge-cortes","institution":"University of Alabama at Birmingham (UAB)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/jorge-cortes","json_url":"https://www.findmykol.com/kol/jorge-cortes/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":3,"publications":4,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-30"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-30"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2025 to 2025","collected_at":"2026-10-30"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-30"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-30"}},"methodology_url":"https://www.findmykol.com/about#methodology"}